Antibody Drug Quantification LC MRM MS
November 4, 2018
Stéphane Parent¹, Anne Jang¹, Michael Schirm¹, Simon Bourque¹, Rudolf Guilbaud¹, Nina Weisser², Gordon Ng², Grant Wickman², Kevin Hamblett² and Lorella Di Donato¹ ¹Caprion Proteomics Inc. ²Zymeworks Inc.
Absolute Quantitation of Five Antibody Drug Products in Dosed Monkey Serum, CSF and Brain Lysate for Lead Candidate Identification Using LC-MRM/MS, AAPS 2018.
Antibody Drug Quantification LC MRM MS
November 4, 2018
Stéphane Parent¹, Anne Jang¹, Michael Schirm¹, Simon Bourque¹, Rudolf Guilbaud¹, Nina Weisser², Gordon Ng², Grant Wickman², Kevin Hamblett² and Lorella Di Donato¹ ¹Caprion Proteomics Inc. ²Zymeworks Inc.
Absolute Quantitation of Five Antibody Drug Products in Dosed Monkey Serum, CSF and Brain Lysate for Lead Candidate Identification Using LC-MRM/MS, AAPS 2018.
Neurodegeneration Biomarkers CSF
June 9, 2017
Pascal Croteau¹, Fiona McAllister¹, Laura McIntosh¹, Laetitia Cortes¹, Michael Schirm¹, Howard Schulman¹, Jane Paulsen², Daniel Chelsky¹. ¹Caprion Biosciences Inc, Montreal, Canada; ²The University of Iowa, Iowa City, IA.
Multiplexed Mass Spectrometry Assay Identifies Neurodegeneration Biomarkers in CSF, CNS Summit 2017
Neurodegeneration Biomarkers CSF
June 9, 2017
Pascal Croteau¹, Fiona McAllister¹, Laura McIntosh¹, Laetitia Cortes¹, Michael Schirm¹, Howard Schulman¹, Jane Paulsen², Daniel Chelsky¹. ¹Caprion Biosciences Inc, Montreal, Canada; ²The University of Iowa, Iowa City, IA.
Multiplexed Mass Spectrometry Assay Identifies Neurodegeneration Biomarkers in CSF, CNS Summit 2017
Biomarkers Alzheimers Disease CSF
June 16, 2013
Daniel S. Spellman¹, Kristin R. Wildsmith², Lee Honigberg², Angus C. Nairn³, Judith A. Siuciak4,7, Mitchell A. Kling5, Howard Schulman6, Michael Schirm6, Daniel Chelsky6, William Z. Potter4,7. Alzheimer’s Disease Neuroimaging Initiative (ADNI) and Foundation for NIH (FNIH) Biomarkers Consortium CSF Proteomics Project Team.
Evaluation of a Multiplexed Mass Spectrometry-Based Method for Measuring Candidate Peptide Biomarkers in Alzheimer’s Disease Neuroimaging Initiative (ADNI) CSF, ASMS 2013.
Biomarkers Alzheimers Disease CSF
June 16, 2013
Daniel S. Spellman¹, Kristin R. Wildsmith², Lee Honigberg², Angus C. Nairn³, Judith A. Siuciak4,7, Mitchell A. Kling5, Howard Schulman6, Michael Schirm6, Daniel Chelsky6, William Z. Potter4,7. Alzheimer’s Disease Neuroimaging Initiative (ADNI) and Foundation for NIH (FNIH) Biomarkers Consortium CSF Proteomics Project Team.
Evaluation of a Multiplexed Mass Spectrometry-Based Method for Measuring Candidate Peptide Biomarkers in Alzheimer’s Disease Neuroimaging Initiative (ADNI) CSF, ASMS 2013.